Epidemiology and diagnosis of brain tumors

CONTINUUM Lifelong Learning in Neurology

Volumn 21, Issue 2, 2015, Pages 301-313

  Butowski, Nicholas A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; ALLERGY; APOPTOSIS; BRAIN METASTASIS; BRAIN TUMOR; CELL METABOLISM; CELL PROLIFERATION; COGNITIVE DEFECT; DIETARY INTAKE; ENVIRONMENTAL FACTOR; EPIDEMIC; FATIGUE; HEAD INJURY; HEADACHE; HEREDITY; HUMAN; INTRACRANIAL TUMOR; MOBILE PHONE; MOLECULAR IMAGING; MORTALITY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SEIZURE; SYMPTOMATOLOGY; TOBACCO; BRAIN NEOPLASMS; ENVIRONMENT; GENETIC PREDISPOSITION; PATHOLOGY; RISK FACTOR;

BRAIN NEOPLASMS; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; RISK FACTORS;

EID: 84926511460     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000464171.50638.fa     Document Type: Review

References (37)

1. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114(2):97-109. doi:10. 1007/s00401-007-0243-4.
2. Ostrom QT, Bauchet L, Davis FG, et al. The epidemiology of glioma in adults: A "state of the science" review. Neuro Oncol 2014;16(7):896-913. doi:10. 1093/neuonc/nou087.
3. Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol 2014;16(suppl 4):iv1Yiv63. doi:10. 1093/neuonc/nou223.
4. Cage TA, Mueller S, Haas-Kogan D, Gupta N. High-grade gliomas in children. Neurosurg Clin N Am 2012;23(3):515-523. doi:10. 1016/j. nec. 2012. 04. 007.
5. Legler JM, Ries LA, Smith MA, et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999;91(16):1382-1390. doi:10. 1093/jnci/91. 16. 1382.
6. Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: Current concepts and review of the literature. Neuro Oncol 2002;4(4):278-299. doi:10. 1093/neuonc/4. 4. 278.
7. Adamson DC, Rasheed BA, McLendon RE, Bigner DD. Central nervous system. Cancer Biomark 2010;9(1-6):193-210. doi:10. 3233/CBM-2011-0177.
8. Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: A clinical review. JAMA 2013;310(17):1842-1850. doi:10. 1001/jama. 2013. 280319.
9. Liu C, Zong H. Developmental origins of brain tumors. Curr Opin Neurobiol 2012;22(5):844-849. doi:10. 1016/j. conb. 2012. 04. 012.
10. Gu J, Liu Y, Kyritsis AP, Bondy ML. Molecular epidemiology of primary brain tumors. Neurotherapeutics 2009;6(3):427-435. doi:10. 1016/j. nurt. 2009. 05. 001.
11. DeyM, Ahmed AU, LesniakMS. Cytomegalovirus and glioma: putting the cart before the horse. J Neurol Neurosurg Psychiatry 2015;86(2): 191-199. doi:10. 1136/jnnp-2014-307727.
12. Myung SK, Ju W, McDonnell DD, et al. Mobile phone use and risk of tumors: A meta-analysis. J Clin Oncol 2009;27(33):5565-5572. doi:10. 1200/JCO. 2008. 21. 6366.
13. Jauchem JR. A literature review of medical side effects from radio-frequency energy in the human environment: involving cancer, tumors, and problems of the central nervous system. J Microw Power Electromagn Energy 2003;38(2):103-123.
14. Inskip PD, Mellemkjaer L, Gridley G, Olsen JH. Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control 1998;9(1):109-116.
15. Burch JD, Craib KJ, Choi BC, et al. An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst 1987;78(4): 601-609.
16. Sheweita SA, Sheikh BY. Can dietary antioxidants reduce the incidence of brain tumors? Curr Drug Metab 2011;12(6):587-593. doi:10. 2174/138920011795713733.
17. Linos E, Raine T, Alonso A, Michaud D. Atopy and risk of brain tumors: A meta-analysis. J Natl Cancer Inst 2007;99(20):1544-1550. doi:10. 1093/jnci/djm170.
18. Drappatz J. Medical care of patients with brain tumors. Continuum (Minneap Minn) 2012;18(2):275-294. doi:10. 1212/01. CON. 0000413658. 04680. 74.
19. Kirby S, Purdy RA. Headaches and brain tumors. Neurol Clin 2014;32(2):423-432. doi:10. 1016/j. ncl. 2013. 11. 006.
20. Nelson S, Taylor LP. Headaches in brain tumor patients: primary or secondary? Headache 2014;54(4):776-785. doi:10. 1111/head. 12326.
21. Mikkelsen T, Paleologos NA, Robinson PD, et al. The role of prophylactic anticonvulsants in the management of brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96(1): 97-102. doi:10. 1007/s11060-009-0056-5.
22. Kerkhof M, Vecht CJ. Seizure characteristics and prognostic factors of gliomas. Epilepsia 2013;54(suppl 9):12-17. doi:10. 1111/epi. 12437.
23. Tremont-Lukats IW, Ratilal BO, Armstrong T, GilbertMR. Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst Rev 2008;(2):CD004424. doi:10. 1002/14651858. CD004424. pub2.
24. Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54(10):1886-1893. doi:10. 1212/WNL. 54. 10. 1886.
25. Van Breemen MS, Wilms EB, Vecht CJ. Seizure control in brain tumors. Handb Clin Neurol 2012;104:381-389. doi:10. 1016/B978-0-444-52138-5. 00026-8.
26. Ahmed R, Oborski MJ, Hwang M, et al. Malignant gliomas: Current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods. Cancer Manag Res 2014;6:149-170. doi:10. 2147/CMAR. S54726.
27. Brandao LA, ShiroishiMS, Law M. Brain tumors: Amultimodality approachwith diffusion-weighted imaging, diffusion tensor imaging, magnetic resonance spectroscopy, dynamic susceptibility contrast and dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Imaging Clin N Am 2013;21(2):199-239. doi:10. 1016/j. mric. 2013. 02. 003.
28. Keogh BP, Henson JW. Clinical manifestations and diagnostic imaging of brain tumors. Hematol Oncol Clin North Am 2012;26(4): 733-755. doi:10. 1016/j. hoc. 2012. 05. 002.
29. Bruzzone MG, D'Incerti L, Farina LL, et al. CT and MRI of brain tumors. Q J Nucl Med Mol Imaging 2012;56(2):112-137.
30. Calabria F, Chiaravalloti A, Di Pietro B, et al. Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT. Nucl Med Commun 2012;33(6):563-570. doi:10. 1097/MNM. 0b013e328351d566.
31. Demetriades AK, Almeida AC, Bhangoo RS, Barrington SF. Applications of positron emission tomography in neuro-oncology: A clinical approach. Surgeon 2014;12(3): 148-157. doi:10. 1016/j. surge. 2013. 12. 001.
32. Herholz K, Langen KJ, Schiepers C, Mountz JM. Brain tumors. Semin Nucl Med 2012;42(6):356-370. doi:10. 1053/j. semnuclmed. 2012. 06. 001.
33. Jarzabek MA, Sweeney KJ, Evans RL, et al. Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): An integrated multidisciplinary commentary. Drug Discov Today 2013;18(21-22):1052-1066. doi:10. 1016/j. drudis. 2013. 06. 004.
34. Patel TR, Yu JB, Piepmeier JM. Role of neurosurgery and radiation therapy in the management of brain tumors. Hematol Oncol Clin North Am 2012;26(4):757-777. doi:10. 1016/j. hoc. 2012. 04. 001.
35. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322(8):494-500. doi:10. 1056/NEJM199002223220802.
36. Huttner A. Overview of primary brain tumors: pathologic classification, epidemiology, molecular biology, and prognostic markers. Hematol Oncol Clin North Am 2012;26(4):715-732. doi:10. 1016/j. hoc. 2012. 05. 004.
37. Pollo B. Pathological classification of brain tumors. Q J Nucl Med Mol Imaging 2012;56(2):103-111.